Clinical Trial Update: DEB-TACE vs cTACE in HCC After TIPS [Phase 3]

View source ↗

Summary

A Phase 3 clinical trial comparing drug-eluting bead TACE (DEB-TACE) with conventional TACE (cTACE) in hepatocellular carcinoma patients after TIPS is currently…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatocellular Carcinoma

Snippet

Sponsor: First Affiliated Hospital, Sun Yat-Sen University | Conditions: Hepatocellular Carcinoma (HCC), TACE | Phase 3 | Status: RECRUITING